Levothyroxine Recall: Subpotent Thyroid Tablets Recalled Across the US
Major Pharmaceuticals has recalled 12 levothyroxine product lines across 7 dosage strengths nationwide. The FDA Class II recall covers subpotent tablets with expiry dates through January 2027.